Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07490015 · ClinicalTrials.gov registry record
Blunt Traumatic Aortic Injury
A clinical trial, sponsored by Methodist Health System.
- Active
- Registry status
- 300
- Enrollment target
NCT07490015: Active study, sponsored by Methodist Health System.
NCT07490015 is a clinical trial that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07490015 is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
Study Summary
This is a retrospective and prospective multi-center observational study of the management and outcomes of BTAI. This study will include patients who meet the registry inclusion criteria as documented in EPIC and chart review will start from January 2019 and December 2028. Data and endpoints will be observational and involve no prescribed therapeutic interventions or alterations in patient care. Institutions and providers will conduct normal diagnosis, management, and surveillance procedures without interference of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-04-08 |
| Est. Completion | 2028-12 |
What the registry record for NCT07490015 still lists
NCT07490015 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07490015 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07490015 about?
NCT07490015 is a clinical study titled "Blunt Traumatic Aortic Injury". This is a retrospective and prospective multi-center observational study of the management and outcomes of BTAI. This study will include patients who meet the registry inclusion criteria as documented in EPIC and chart review will start from January 2019 and December 2028. Data and endpoints will be...
What is the current status of trial NCT07490015?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2024-04-08. Estimated completion is 2028-12.
Who is sponsoring clinical trial NCT07490015?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI